Boston Scientific Corporation

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices. Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. The company advances science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Company Growth (employees)
Type
Public
HQ
Marlborough, US
Founded
1979
Size (employees)
27,000 (est)+8%
Boston Scientific Corporation was founded in 1979 and is headquartered in Marlborough, US

Key People at Boston Scientific Corporation

Michael F. Mahoney

Michael F. Mahoney

Chairman and Chief Executive Officer

Boston Scientific Corporation Office Locations

Boston Scientific Corporation has offices in Marlborough, Voisins-le-Bretonneux, Singapore, Arden Hills and in 7 other locations
Marlborough, US (HQ)
100 Boston Scientific Way
Sandton, ZA
Anslow Ln
Üsküdar, TR
45 Ord. Prof. Dr. Fahrettin Kerim Gökay Cd.
Gurugram, IN
48 Sohna Rd
Maple Grove, US
1 Scimed Pl
Huangpu Qu, CN
Meng Zi Lu
Show all (11)

Boston Scientific Corporation Data and Metrics

Boston Scientific Corporation Financial Metrics

Boston Scientific Corporation's revenue was reported to be $8.4 b in FY, 2016 which is a 12% increase from the previous period.
USD

Revenue (FY, 2016)

8.4 b

Revenue growth (FY, 2015 - FY, 2016), %

12%

Gross profit (FY, 2016)

6 b

Gross profit margin (FY, 2016), %

71%

Net income (FY, 2016)

347 m

EBIT (FY, 2016)

447 m

Market capitalization (18-Aug-2017)

37.4 b

Cash (31-Dec-2016)

196 m

EV

42.6 b
Boston Scientific Corporation's current market capitalization is $37.4 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

7.1 b7.4 b7.5 b8.4 b

Revenue growth, %

3%1%12%

Cost of goods sold

2.2 b2.2 b2.2 b2.4 b

Gross profit

5 b5.2 b5.3 b6 b

Gross profit Margin, %

70%70%71%71%

EBIT

120 m(301 m)(327 m)447 m

EBIT margin, %

2%(4%)(4%)5%

Pre tax profit

(223 m)(509 m)(650 m)177 m

Net Income

(121 m)(119 m)(239 m)347 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

217 m587 m319 m196 m

Inventories

897 m946 m1 b955 m

Current Assets

3 b3.6 b3.5 b3.2 b

PP&E

1.5 b1.5 b1.5 b1.6 b

Goodwill

5.7 b5.9 b6.5 b6.7 b

Total Assets

16.6 b17 b18.1 b18.1 b

Accounts Payable

246 m262 m209 m447 m

Total Debt

4.2 b3.9 b5.7 b5.4 b

Current Liabilities

1.8 b2.8 b2.4 b3.6 b

Additional Paid-in Capital

16.6 b16.7 b16.9 b17 b

Retained Earnings

(8.6 b)(8.7 b)(8.9 b)(8.6 b)

Total Equity

6.5 b6.5 b6.3 b6.7 b

Debt to Equity Ratio

0.6 x0.6 x0.9 x0.8 x

Debt to Assets Ratio

0.3 x0.2 x0.3 x0.3 x

Financial Leverage

2.5 x2.6 x2.9 x2.7 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(121 m)(119 m)(239 m)347 m

Accounts Receivable

(101 m)53 m(17 m)(216 m)

Inventories

(7 m)(81 m)3 m40 m

Accounts Payable

(37 m)620 m(20 m)553 m

Cash From Operating Activities

1.1 b1.3 b600 m972 m

Purchases of PP&E

(245 m)(259 m)(247 m)(376 m)

Interest Paid

329 m221 m283 m233 m

Income Taxes Paid

67 m74 m80 m94 m
USDY, 2016

EV/EBIT

95.4 x

EV/CFO

43.9 x

Revenue/Employee

322.5 k

Debt/Equity

0.8 x

Debt/Assets

0.3 x

Financial Leverage

2.7 x

Boston Scientific Corporation Operating Metrics

Boston Scientific Corporation's Customers was reported to be 35 k in FY, 2016
FY, 2016

Customers

35 k

Countries

120

Facilities

13

Boston Scientific Corporation Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
SymetisMarch 30, 2017$435 m

Boston Scientific Corporation Market Value History

Boston Scientific Corporation Revenue Breakdown

Boston Scientific Corporation Median Salaries

Source: 206 public H-1B filings from Boston Scientific Corporation

Traffic Overview of Boston Scientific Corporation

Boston Scientific Corporation Online and Social Media Presence

Boston Scientific Corporation News and Updates

Attacking Hearing Loss, Brain Injury, And More: 12 Early-Stage Medical Device Startups To Watch

Since 2012, deals to early-stage medical device companies have hovered around 30% of total deal volume to the category. VCs and corporate investors alike are continuing to fund medical device startups in 2016 and the category is on track to see another year of increased … Continued

Redefining The Future of Medicine: 72 Medical Device Startups Advancing Treatment And Prevention

Medical device funding is on track to reach $3.5B in 2016, a slight increase over last year’s dollar total. Since 2012, most funding to medical device startups has occurred in the United States, with NEA leading venture capital activity and Johnson & … Continued

Corporates Ramp Up Involvement In Medical Device Industry

Corporations and their investment arms — including Johnson & Johnson, Kaiser Permanente, and Medtronic — have been participating in major deals to medical device startups. These include large late-stage deals into CVRx, Acutus Medical, and Transmedics. Additionally, deals with corporate backing …

Boston Scientific Corporation Company Life and Culture

You may also be interested in